As mentioned previously, liraglutide, dulaglutide, albiglutide, and semaglutide have been shown to reduce the risk of cardiovascular events in patients with diabetes and either established ASCVD or high-risk characteristics in randomized controlled trials [35, 36, 49]
doi: 10.1093/bioinformatics/18.suppl_1.S71 47 AshkenazyHAbadiSMartzEChayOMayroseIPupkoTet al
If you are managing other health conditions or medications, a slower titration gives you and your healthcare provider more time to monitor interactions and adjust other treatments as needed
A recent study projects that if all eligible adults had access, over 50,000 deaths could be prevented annually, including more than 11,000 with type 2 diabetes
Compounded, not FDA-approved finished drugs